{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 22, "transaction_limit": 160, "filters": {"q": "", "ticker": "PSTV", "sector": "", "industry": "", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 22, "acquisition_count": 11, "disposal_count": 11, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 0.0, "disposal_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "flow_tone": "neutral", "largest_value_label": "$0", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 22, "value": "0.0000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$0"}], "days": [{"transaction_date": "2026-07-01", "acquisitions": 11, "disposals": 11, "total": 22, "bar_width": 100.0}], "side_mix": {"acquisitions": 11, "disposals": 11, "acquisition_share": 50.0, "disposal_share": 50.0}}, "company_flows": [{"symbol": "PSTV", "name": "Plus Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-01", "acquisitions": 11, "disposals": 11, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 50.0, "disposal_share": 50.0, "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}], "company_overview": [{"symbol": "PSTV", "name": "Plus Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-01", "filings": 22, "acquisitions": 11, "disposals": 11, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 50.0, "disposal_share": 50.0, "tone": "Mixed flow", "tone_class": "neutral", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}], "transactions": [{"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "ANDREWS, RONALD ASBURY", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 922.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.266552+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "ANDREWS, RONALD ASBURY", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 922.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.265161+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "CLOWES, HOWARD", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 922.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.284090+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "CLOWES, HOWARD", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 922.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.240973+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "GUSE, KYLE", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 922.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.261992+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "GUSE, KYLE", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 922.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.274524+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "HAWKINS, RICHARD J", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 922.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.260227+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "HAWKINS, RICHARD J", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 922.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.282544+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "HEDRICK, MARC H", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 1986.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.271475+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "HEDRICK, MARC H", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 6387.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.268278+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "HEDRICK, MARC H", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 8066.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.269882+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "HEDRICK, MARC H", "executive_title": "Director, Chief Executive Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 6387.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.273108+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "HEDRICK, MARC H", "executive_title": "Director, Chief Executive Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 8066.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.276043+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "HEDRICK, MARC H", "executive_title": "Director, Chief Executive Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 1986.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.277509+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "SIMS, ANDREW JOHN HUGH MACINTYRE", "executive_title": "Chief Financial Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 287.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.258373+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "SIMS, ANDREW JOHN HUGH MACINTYRE", "executive_title": "Chief Financial Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 1533.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.255186+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "SIMS, ANDREW JOHN HUGH MACINTYRE", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 287.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.253496+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "SIMS, ANDREW JOHN HUGH MACINTYRE", "executive_title": "Chief Financial Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 1165.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.256770+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "SIMS, ANDREW JOHN HUGH MACINTYRE", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 1533.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.263528+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "SIMS, ANDREW JOHN HUGH MACINTYRE", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 1165.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.251824+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "VAN, ES-JOHANSSON AN", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 922.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.279158+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}, {"symbol": "PSTV", "name": "Plus Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "VAN, ES-JOHANSSON AN", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 922.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:11:24.280981+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pstv/", "research_links": {"chart": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/", "report": "/terminal/e644d32d-9f57-41ad-9510-648b896d4c8d/report/", "factor": "/factors/ticker/e644d32d-9f57-41ad-9510-648b896d4c8d/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}